Posts tagged “NCBIO”
If your early-stage life science company needs some funding help, you still have a few days to apply for a chance to pitch your company story to investors and colleagues at the 2016 annual Southeast BIO Investor & Partnering Forum.
Power pro-business advocacy groups who also have a focus on or include members of the high tech and life science industries are either analyzing the recently passed Public Facilities Privacy & Security Act or steering clear of any comment.
From gene editing to microbiome, precision medicine to big data and more: NC's bright biotech future
Doug Edgeton, CEO of the North Carolina Biotechnology Center, gave a thumb's up overview about the state's life science sector in a briefing to the boards of the Biotech Center, the CED and NCBio earlier this week. Here's a recap.
NCBIO, the trade organization for North Carolina biotechnology companies, expects about 200 to 250 at its annual meeting at the NC Biotechnology Center Thursday. Sam Taylor, NCBIO president, said that in addition to two key note speakers, the event includes a review of state and federal policies related to biotech, including what the NC legislature did this year.
Thirteen emerging startup life science companies will share the spotlight at the annual Life Science Conference put on by the Council for Entrepreneurial Development, NCBIO and the North Carolina Biotechnology Center in Raleigh.
"Innovation isn't important simply because it creates something new - it's only important if what it creates makes a meaningful and positive difference in people's lives," says FDA Commissioner Dr. Margaret Hamburg.
LabCorp, the global lab testing firm based in Burlington, and its Chief Executive Officer David King are the host for "Venture Day" at the CED's annual life science conference.
Dr. Jack Szostak, a 2009 Nobel Prize winner and a professor of genetics at Harvard, headlines the program for the 22nd CED Life Science Conference next month.
The N.C. Biotechnology Center and other representatives for the state's biotech industry will have a new 3,000 square foot pavillion at the BIO International Convention.
In a state where biotech dominates life science headlines, device company execs and CED band together to raise the industry profile. They also want other companies to become more aware of N.C.’s advantages as a home for emerging ventures.
Biotech, pharmaceutical and medical science firms across the state form ‘one of the biggest life science engines in the country,’ NCBIO executive tells group at kickoff event. He cautions against changes that would ‘undermine’ that engine.